Leo Cancer Care is committed to challenging the conventions of radiotherapy by reintroducing the practice of treating patients in an upright position, providing an improved patient experience and products designed for economies of the future.

Leo Cancer Care

TibaRay develops ultra-fast and ultra-precise technology aimed at improving radiotherapy for cancer treatment. Self-described as a significant technological advancement in the field.

TibaRay

Leo Cancer Care is committed to challenging the conventions of radiotherapy by offering upright positioning solutions designed to improve patient experience and reduce economic costs in radiation therapy.

Leo Cancer Care | 9,872 followers on LinkedIn. THE MORE HUMAN WAY TO TREAT CANCER | LEO CANCER CARE WAS FOUNDED WITH TWO POWERFUL GOALS

 1. Improve the quality of Radiation Therapy delivery through upright positioning 

2. Improve access to Radiation Therapy through the removal of gantries

Leo Cancer Care was founded with more than 100 years of Radiation Therapy experience by a team dedicated to challenging the norms in everything we do.

AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…

Dr. D. Martin Alexander Gershon, MD, JD, MPH

Mark Kenneally

Gerald Fordyce

Partner at Artiman Ventures; Board Member at Artiman companies; Independent Director; former CEO of BioImagene (acquired by Roche); former CEO of…

Ajit Singh

We're #hiring a new Manufacturing Test Technician in Crawley, England. Apply today or share this post with your network.

🚀 New Partnership Announcement! 🚀 We’re thrilled to announce our new partnership with Anzai Medical Co., Ltd. This collaboration marks a significant step in expanding access to the latest advancements in radiation therapy, with a shared mission to enhance patient care through efficiency, comfort, and adaptability. “We are thrilled to partner with Anzai Medical, whose expertise and commitment to providing top-tier medical solutions align perfectly with our vision to make cancer treatment more patient-centric and accessible. Together, we aim to transform the landscape of cancer care in Japan and ensure that more patients can benefit from cutting-edge treatment technologies.” Stephen Towe, CEO of Leo Cancer Care As a leader in advancing healthcare and embracing innovative solutions, Japan is the ideal location to pioneer the emerging practice of upright radiotherapy, setting the stage for transformative cancer treatment. 📌 Read the full announcement - https://obi41.nl/2p9y2a5w #LeoCancerCare #AnzaiMedical #RadiationTherapy #CancerCare #PatientCenteredCare #Innovation

⭐ We are excited to announce that we will be attending the 37th Annual Meeting of the Japanese Society for Radiation Oncology!⭐ Join us as we showcase our innovative advancements in radiation therapy, including the Marie system, designed for enhanced patient comfort and treatment efficiencies through its unique upright patient positioning. We look forward to connecting with industry leaders and exploring new ways to bring improved patient and clinician experience to patients worldwide with our particle beam-agnostic approach. See you at #JASTRO2024 ! #RadiationOncology #PatientCare #Innovation #JASTRO

🌸It's Breast Cancer Awareness month💚 Globally, 2.3 million people receive a breast cancer diagnosis annually and it accounts for 15% of all new cancer cases in the UK (Cancer Research UK). With self-examination being the most common method of breast cancer identification it is vital we know what signs to look out for and how to self-examine as well attending regular screening appointments. Macmillan Cancer Support has valuable information on their website about how to examine yourself, what to look out for and what receiving a breast cancer diagnosis means. There is also a heartwarming story from Bami on why being breast-aware is so important. . https://obi41.nl/yrrr2cym #BreastCancerAwareness #PinkOctober #EarlyDetectionSavesLives

Bigger isn’t always better! 👌 A simple shift from beam rotation to patient rotation will deliver BIG benefits in size, cost, and accessibility. Read more on our brand-new particle therapy page: https://lnkd.in/ekJ5ynkq #particletherapyinreachforall #morehuman #uprightradiotherapy

Next stop: Photons! 🚀 We're excited to announce the launch of the Upright Photon Alliance! Hear from founding member Benjamin (BJ) Sintay , Executive Director of Radiation Oncology at Cone Health . Having a community-based partner like Cone Health on board aligns perfectly with our mission to improve accessibility and the treatment experience for patients worldwide. Stay tuned for more! #uprightphotonalliance #uprightradiotherapy #morehuman

Revolutionizing radiotherapy, one beam at a time. ⚡ Our Marie solution is designed to be beam agnostic and open to integrating with any fixed particle beam. Read more about our existing and new partnerships in our latest article: https://lnkd.in/eQjTzWS9 Mevion Medical Systems , Hitachi , Linearbeam - Protons for Life , ProTom International , ProNova Solutions , Aviko Radiopharmaceuticals , Neutron Therapeutics LLC , THERYQ . Our goal is to make advanced cancer treatments more accessible and to push the boundaries of what's possible. #partnerships #beamagnostic #uprightradiotherapy

Cancer doesn’t discriminate—it touches us all. At Leo Cancer Care, we're reintroducing an old idea with a new spin: radiation therapy in the position we naturally live—upright. We believe our approach will change how we think about radiotherapy for good. #uprightradiotherapy #morehuman #challengingthenorms Please note: The Leo Cancer Care technology is not yet clinically available.

History is unfolding at McLaren Flint ! The center is excited as they prepare to become the world’s first to treat with our Marie solution. In the reimagined treatment space—two rooms that once formed a single gantry vault—a fixed proton beam stands ready. We’ve captured this incredible milestone on camera and can’t wait to share a series of videos with you soon! #historyinthemaking #pioneers #morehuman

We are excited to announce the launch of UPLIFT, a multi-million euro research and training project on upright radiotherapy. Leo Cancer Care is 1 of 15 prestigious scientific institutions and industrial partners involved in this project which will support PhD students through three upright radiotherapy research areas. The project is supported by a substantial research investment from the Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks which shows recognition of the global potential of upright radiotherapy to deliver clinical benefits and improve treatment accessibility. https://obi41.nl/y3r6m56c #UPLIFT #UprightRadiotherapy #Research GSI Helmholtz Centre for Heavy Ion Research DKFZ German Cancer Research Center Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Czech Technical University in Prague Centre Léon Bérard TheraPanacea ASG Superconductors S.p.A. Centro Nazionale di Adroterapia Oncologica (CNAO) Jagiellonian University Cosylab RaySearch Laboratories PSI Paul Scherrer Institut Sheffield Hallam University Loughborough University

Metric
Company Name	Leo Cancer Care	TibaRay
Symbol
MSH ID	COM:LEOCANCERCARE	COM:TIBARAY
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices	Medical Technology
Country	GB	US
Stage
Employee Count	11	11
Website	leocancercare.com	tibaray.com
LinkedIn	leocancercare	tibaray-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.42K	49
Web Traffic Growth	-0.70
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

LEOC

COM:LEOCANCERCARE

Leo Cancer Care

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue